問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Kaohsiung Medical Univeristy Chung-Ho Memorial Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2021-04-01 - 2027-01-30
Condition/Disease
Test Drug
Participate Sites2Sites
Recruiting2Sites
2022-12-01 - 2027-11-14
Participate Sites4Sites
Recruiting4Sites
2023-03-01 - 2027-02-28
Participate Sites16Sites
Recruiting16Sites
2022-09-30 - 2026-04-30
Participate Sites5Sites
Recruiting5Sites
2024-05-01 - 2028-12-31
2024-10-24 - 2027-07-15
2023-03-01 - 2027-04-30
Atherosclerotic Cardiovascular Disease
olpasiran (AMG 890)
Participate Sites10Sites
Recruiting9Sites
Terminated1Sites
Division of General Internal Medicine
2022-04-01 - 2027-01-31
Participate Sites6Sites
Recruiting6Sites
2024-12-17 - 2030-08-23
2023-12-22 - 2029-10-31
Participate Sites3Sites
全部
